Vnitr Lek 2014, 60(10):908-910

Aktualizované stanovisko České společnosti pro hypertenzi k provádění renálních denervací u rezistentní hypertenze

Jan Filipovský1,*, Václav Monhart2,3, Jiří Widimský jr4
1 II. interní klinika LF UK a FN Plzeň, přednosta prof. MUDr. Jan Filipovský, CSc.
2 Interní klinika 1. LF UK a ÚVN - Vojenská fakultní nemocnice Praha, přednosta prof. MUDr. Miroslav Zavoral, Ph.D.
3 Synlab Czech s.r.o., Interní, diabetologická a nefrologická ambulance, Praha
4 III. interní klinika 1. LF UK a VFN Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA

Received: October 7, 2014; Published: October 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Filipovský J, Monhart V, Widimský J. Aktualizované stanovisko České společnosti pro hypertenzi k provádění renálních denervací u rezistentní hypertenze. Vnitr Lek. 2014;60(10):908-910.
Download citation

References

  1. Widimský P, Filipovský J, Widimský J jr et al. Odborné stanovisko České kardiologické společnosti a České společnosti pro hypertenzi k provádění katetrizačních renálních denervací (RDN) v České republice. Hypertenze a Kardiovaskulární prevence 2012; 1(1): 5-9. Cor et Vasa 2012; 54(3-4): 155-159. Go to original source...
  2. Esler MD, Krum H, Sobotka PA et al. Renal sympathetic denervation in patients with treatment - resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010; 376(9756): 1903-1909. Go to original source... Go to PubMed...
  3. Bhatt DL, Kandzari DE, O'Neill WW et al. on behalf of the SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370(15): 1393-1401. Go to original source... Go to PubMed...
  4. Persu A, Jin Y, Azizi M et al. European Network COordinating research on Renal Denervation (ENCOReD). Blood pressure changes after renal denervation at 10 European expert centers. J Hum Hypertens 2014; 28(3): 150-156. Go to original source... Go to PubMed...
  5. Toušek P, Widimský J jr, Rosa J et al. Catheter-based renal denervation versus intensified medical treatment in patients with resistant hypertension: Rationale and design of a multicenter randomised study - Prague-15. Cor et Vasa 2014; 56(2): e235-e239. Dostupné z WWW: <http://www.e-coretvasa.cz/casopis/view?id=5617>. Go to original source...
  6. Fadl Elmula FE, Hoffmann P, Larstorp AC et al. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension. Hypertension 2014; 63(5): 991-999. Go to original source... Go to PubMed...
  7. Ezzahti M, Moelker A, Friesema ECH et al. Blood pressure and neurohormonal responses to renal nerve ablation in treatment-resistant hypertension. J Hypertension 2014; 32(1): 135-141. Go to original source... Go to PubMed...
  8. Papademetriou V, Tsioufis CP, Sinhal A et al. Catheter-Based Renal Denervation for Resistant Hypertension: 12-Month Results of the EnligHTN I First-in-Human Study Using a Multielectrode Ablation System. Hypertension 2014; 64(3): 565-572. Go to original source... Go to PubMed...
  9. Persu A, Jin Y, Baelen M et al. on behalf of the European Network Coordinating research on REnal Denervation (ENCOReD) Consortium. Eligibility for renal denervation. Experience at 11 European Expert Centers. Hypertension 2014; 63(6): 1319-1325. Go to original source... Go to PubMed...
  10. Rosa J, Zelinka T, Petrák O et al. Importance of thorough investigation of resistant hypertension before renal denervation: should compliance to treatment be evaluated systematically? J Human Hypertension 2014 28(11): 684-688. doi: 10.1038/jhh.2014.3. Go to original source... Go to PubMed...
  11. Templin C, Jaguszewski M, Ghadri JR et al. Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity catheter system and the EnligHTN multi-electrode renal denervation catheter. Eur Heart J 2013; 34(28): 2141-2148. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.